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Background: The histone H3 variant CENP-A is normally tightly regulated to ensure only one centromere exists per
chromosome. Native CENP-A is often found overexpressed in human cancer cells and a range of human tumors.
Consequently, CENP-A misregulation is thought to contribute to genome instability in human cancers. However,
the consequences of such overexpression have not been directly elucidated in human cancer cells.
Results: To investigate native CENP-A overexpression, we sought to uncover CENP-A-associated defects in human
cells. We confirm that CENP-A is innately overexpressed in several colorectal cancer cell lines. In such cells, we report
that a subset of structurally distinct CENP-A-containing nucleosomes associate with canonical histone H3, and with
the transcription-coupled chaperones ATRX and DAXX. Furthermore, such hybrid CENP-A nucleosomes localize to
DNase I hypersensitive and transcription factor binding sites, including at promoters of genes across the human
genome. A distinct class of CENP-A hotspots also accumulates at subtelomeric chromosomal locations, including at
the 8q24/Myc region long-associated with genomic instability. We show this 8q24 accumulation of CENP-A can also
be seen in early stage primary colorectal tumors.
Conclusions: Our data demonstrate that excess CENP-A accumulates at noncentromeric locations in the human
cancer genome. These findings suggest that ectopic CENP-A nucleosomes could alter the state of the chromatin
fiber, potentially impacting gene regulation and chromosome fragility.Background
Hallmarks of the cancer state include large-scale gene
expression changes [1], chromosomal rearrangement,
and aneuploidy [2-6]. While the mechanistic basis for
these events remains under investigation, such events
have been attributed to DNA methylation changes [1],
telomere disruption [7], repair and DNA damage pathway
protein defects [8], replication distress [9], and misregula-
tion of the centromere-specific histone H3 variant, CENP-
A [10-13]. CENP-A’s normal function is to serve as the sole
structural marker for centromeric chromatin identity [14],
by directly associating with a triad of inner kinetochore* Correspondence: dalaly@mail.nih.gov
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unless otherwise stated.proteins CENP-C, CENP-N and CENP-B [15], which in
turn recruit the rest of the kinetochore and microtubules
to ensure faithful genome segregation during mitosis [16].
Consequently, mislocalization of CENP-A to noncentro-
mere regions is believed to be a prognostic marker for
aneuploidies driven by chromosomal breakage and rear-
rangements, emanating from bicentric chromosomes
[10,11,13,17,18]. Indeed, artificial overexpression studies in
flies demonstrate that under certain conditions, CENP-A
can seed neocentromeres [17,19]. However, when moder-
ately overexpressed to the levels similar to that previously
seen in cancer cells [10,11], CENP-A does not easily seed
neocentromeres [20], but rather expands centromere
domains [21]. In related studies, overexpressed yeast or
Drosophila CENP-A accumulates in the euchromatic arms,
where it is continually targeted for proteolysis and subse-
quently degraded [22,23]. Indeed, a recent study confirms
this occurs also in human HeLa cells, wherein forced. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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mulation at ectopic locations [24]. However, although
CENP-A mRNA is innately overexpressed several fold in a
number of human solid tumors, including colorectal
tumors [10,11,18,25-27], its behavior in cancer cells has
not been investigated.
To elucidate consequences associated with CENP-A
misregulation, we examined CENP-A mRNA and protein
levels, partners, structure, and global nucleosome occu-
pancy in human primary normal and colorectal cancers
cells, as well as in primary tumors. We report that CENP-
A is overexpressed at the mRNA and protein level in some
human colorectal cancers. This excess CENP-A partners
with histone H3, and associates with transcriptionally
coupled chaperones ATRX and DAXX in colorectal
cancer cell lines. This distinct class of noncentromeric
CENP-A nucleosomes forms a stable octameric nucleo-
somal species as detected by atomic force microscopy
(AFM) and confirmed by high-resolution DNA analysis,
which demonstrates binding of 150 to 170 bp of DNA.
These distinctive CENP-A nucleosomes localize to open
regions of the genome as mapped by DNase I hypersensi-
tivity (DHS), such as promoters of genes, and contain
transcription factor binding motifs. In addition, we observe
a correlation between large clusters of CENP-A and subte-
lomeric locations including the fragile region at 8q24. In
this 8q24 region, we show that CENP-A is bound to
CENP-C, a phenomena that also occurs in early human
colorectal tumors, but not in normal human colon cells.
Taken together, our data uncover a new role for a classical
histone variant in human cancer cell lines.
Results
CENP-A is overexpressed, and ectopic CENP-A nucleosomes
associate with H3, ATRX, and DAXX in colorectal cancer cells
Early reports of innate overexpression of CENP-A in colo-
rectal tumors date back well over a decade [10]. Thus, we
focused on well-characterized colorectal cancer cell lines
derived from different stages of tumor progression, such
as SW480, HT29, DLD-1, and HCT116, comparing them
to normal colon cells. We also included HeLa cells, since
they have long been used as a model for human centro-
mere biology [28,29]. We first examined total nuclear
CENP-A protein across all the cell lines, using a sensitive
fluorescence-based quantitative western blotting system
(Figure 1A). Relative to normal colon cells, and stan-
dardized against internal amounts of the core histone
H4, we observed CENP-A protein levels were slightly
elevated in HeLa cells, lower in DLD-1, 1.35 fold over-
expressed in HT29 and almost twofold overexpressed in
the cell line SW480 (Figure 1A lower graph and Table 1
lists fold-values of all proteins tested in Figure 1A). To test
whether the excess CENP-A protein in SW480 derived
from excess mRNA, we next examined total CENP-AmRNA levels. Indeed, semi-quantitative PCR analysis indi-
cated that CENP-A mRNA is almost fourfold overex-
pressed in SW480 cells compared to normal colon cells
(Figure 1B, lower panel depicts graphical representation of
4 replicates). We next examined levels of the CENP-A
chaperone Holliday junction recognition protein (HJURP),
which is required for accurate loading of CENP-A to cen-
tromeres [30-32]. Surprisingly, HJURP levels do not fol-
low those of CENP-A; the cell line possessing the most
CENP-A (SW480) has normal amounts of HJURP
(Table 1). This finding intrigued us because, under normal
conditions, HJURP restricts CENP-A loading to centro-
meric nucleosomes. We wondered whether histone H3
variant chaperones were also misregulated. We assessed
transcription-coupled histone chaperones ATRX and
DAXX, and observed that both are overexpressed in most
cancer cell lines relative to normal colon, ranging from
three- to twentyfold excess protein (Figure 1A, Table 1).
Thus, these data demonstrate that CENP-A gene expres-
sion is innately misregulated in some colorectal cancer
cells. To examine the consequences of variable amounts
of this key histone variant, we chose to focus the rest of
the study on three cell lines, spanning normal (normal
colon), moderate (HeLa), and high (SW480) levels of
CENP-A protein.
Histone variants such as H3.3/H2A.Z, which use chap-
erones like ATRX/DAXX, are generally excluded from
centromeric CENP-A nucleosomes, and found either at
pericentric regions [33] or at promoters of genes [34].
We wanted to assess potential co-occupancy of H3/
H2A.Z and CENP-A, when CENP-A and ATRX are mis-
regulated, as well as potential sites in the genome where
such co-associations might occur. To enrich for poten-
tial ectopic CENP-A nucleosomes, which might be at
low abundance across the genome, we first devised a
scheme to enrich noncentromeric CENP-A (Figure 1C
shows a brief outline of the method). We used moder-
ately micrococcal nuclease (MNase) digested nucleo-
somal arrays (Figure 1D) from normal colon, HeLa, and
SW480 colorectal cells. From these inputs, we sought to
enrich centromere-specific CENP-A nucleosomes
(henceforth referred to as ‘centromeric CENP-A’) using
native immunoprecipitation (IP) for the inner kineto-
chore protein CENP-B. CENP-B specifically binds a
motif found in most centromeric alpha satellite DNA at
every alternate CENP-A nucleosome in active centro-
meres [35]. Gentle sequential native CENP-A IP was ap-
plied to nucleosomes left unbound (UB) from this first
step in order to enrich for centromere-depleted CENP-
A nucleosomes (henceforth referred to as ‘ectopic
CENP-A’). While this scheme does not allow for abso-
lute elimination of centromeric CENP-A nucleosomes
(due to the fact that CENP-A can localize to autosomal
alpha satellite regions lacking CENP-B box), ectopic
Figure 1 (See legend on next page.)
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Table 2 Protein levels of CENP-A, CENP-B, H2A.Z, H3, ATRX,
and DAXX in normal and cancer cell lines
Normal HeLa SW480
(See figure on previous page.)
Figure 1 CENP-A is overexpressed in colon cancer SW480 cells, and associates with H3, ATRX, and DAXX. (A) Upper panel: Western blot
(WB) analysis of total nuclear CENP-A, HJURP, ATRX, and DAXX, relative to core histone H4 across cell lines. Lower panel: quantification of CENP-A
protein expression standardized to normal colon (replicate data from Table 1), error bars = SEM. (B) Upper panel: semi-quantitative PCR analysis of
CENP-A mRNA expression in normal and SW480 cells in three replicates. Lower panel: quantification of the CENP-A mRNA expression normalized
to β-actin from four experiments, error bars = SEM. (C) Scheme depicting strategy to separate centromeric from ectopic CENP-A nucleosomes
and subsequent experiments performed with each fraction. (D) Micrococcal nuclease (MNase) ladders of input chromatin used subsequently in
the primary CENP-B chromatin immunoprecipitation (ChIP) for normal, HeLa and SW480 cell lines demonstrates that mostly mono-, di-, and
tri-nucleosomal arrays are present in the input chromatin. Slight variations in digestibility derive from intrinsic variability in the different cell lines’
biology. (E) WB slice panels show CENP-B, CENP-A, H2A.Z, and H3 protein analysis from CENP-B IP and sequential CENP-A IP from normal, HeLa,
and SW480 cells. Mock immunoprecipitation (IP) indicates control immunoprecipitation with nonspecific IgG. Recombinant CENP-A (Rec. CpA)
was used as a detection specificity control. Gray CENP-A arrow in third row indicates a band that was already present prior to H2A.Z probing.
Data quantification is provided in Table 2. (F) WB for ATRX and DAXX in normal, HeLa, and SW480 CENP-B IPs versus ectopic CENP-A IPs
(data summarized in Table 2).
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ences in composition and structure using biochemical
and nanomolecular tools [36]. We also performed mock
IPs to ensure that background levels of histones sticking
to immune-beads could be factored in for each experi-
ment that followed. The resultant sets of IPs were then
resolved on high-resolution protein gels and probed for
CENP-B, CENP-A, H2A.Z, and H3 by quantitative two-
color fluorescent WB. We observed a significant frac-
tion of ectopic CENP-A present in normal colon cells,
but relatively inefficient CENP-B pre-clearing (most
likely due to a low abundance of extracted protein from
that cell line) made the interpretation difficult (Figure 1E
and Table 2). In contrast, CENP-B pre-clearing of nu-
clear extracts from HeLa and SW480 cancer cells was
robust. Six- to seven-fold enrichment of CENP-B was
observed in the CENP-B IP compared to the sequential
CENP-A IP, indicating efficient centromeric chromatin
depletion, leaving behind a pool of non-CENP-B associ-
ated CENP-A nucleosomes (Figure 1E and Table 2). The
sequential CENP-A IP demonstrated a 3-fold enrich-
ment of ectopic CENP-A nucleosomes compared to the
centromeric fraction in SW480 cells, which constituted
a 10-fold increase in comparison to HeLa, wherein
ectopic CENP-A is depleted with regard to the centro-
meric fraction (3.02 versus 0.32 enrichment for SW480Table 1 CENP-A, ATRX and DAXX are overexpressed in
colorectal cell lines
Cell Line CENP-Aa HJURPa ATRXa DAXXa
Normal colon 1 1 1 1
DLD1 0.57 ± 0.12 2.19 ± 0.73 9.40 ± 1.25 1.22 ± 0.12
HeLa 1.26 ± 0.09 1.55 ± 0.55 5.22 ± 0.14 2.07 ± 0.07
HCT116 1.32 ± 0.10 2.89 ± 0.95 13.94 ± 4.01 3.66 ± 0.15
HT29 1.35 ± 0.11 4.69 ± 1.80 19.05 ± 8.10 3.18 ± 0.15
SW480 1.75 ± 0.23 1.24 ± 0.25 22.40 ± 3.91 2.80 ± 0.22
aFold-changes in each protein (CENP-A, HJURP, ATRX and DAXX) were calculated
as the ratio of that protein/H4 divided by ratio of the same protein/H4 in normal
colon cells. Data represents 3 replicates.and HeLa, respectively). Although no appreciable in-
crease in H2A.Z was seen in the ectopic fraction of
CENP-A, a threefold enrichment of canonical histone
H3 in ectopic CENP-A IP was observed in SW480
compared to HeLa or normal colon cells. These data
suggested co-occupancy or increased proximity of H3
and CENP-A in colorectal cancer cells (2.91 versus 0.98
H3 enrichment for SW480 and HeLa, respectively).
A recent study has reported that artificially overex-
pressed tagged CENP-A associates with the H3.3 chape
rone DAXX in HeLa cells [24]. Since both, ATRX and
DAXX, were overexpressed in HeLa and SW480 cells
relative to normal (Figure 1A), we next investigated
association of these chaperones with centromeric and
ectopic CENP-A IPs from normal colon, HeLa, and
SW480 cells. We noted a strong association between
these chaperones and CENP-A in colorectal cancer
cells (Figure 1F, Table 2). In contrast to a recent report
demonstrating that artificially overexpressed CENP-A
relies on DAXX/ATRX to associate at ectopic locations,
we were unable to conclude that there was specific
enrichment exclusive to the ectopic CENP-A fraction,CpB fold enrichment
(CpB IP/seq. CpA IP)a
1.67 5.90 7.59
Ectopic CpA fold enrichment
(Seq. CpA IP/CpB IP)a
0.54 0.32 3.02
H2A.Z fold enrichment
(Seq. CpA IP/CpB IP)a
0.87 0.87 1.08
H3 fold enrichment
(Seq. CpA IP/CpB IP)a
1.00 0.98 2.91
ATRX fold enrichment
(Seq. CpA IP/CpB IP)a
- 1.06 0.81
DAXX fold enrichment
(Seq. CpA IP/CpB IP)a
- 1.50 0.72
aFluorescent western blot signals from Figure 1E and F were quantified on
Odyssey Li-Cor, background-corrected, and input-adjusted fold-ratios between
immunoprecipitations (IPs) were calculated as indicated.
Figure 2 Ectopic CENP-A forms a structurally distinct type of
nucleosome in colorectal cancer cells. Atomic force microscopy
(AFM) analysis of nucleosomal heights from SW480 total input
chromatin, in vitro reconstituted chromatin containing either H3 or
CENP-A octameric nucleosomes, SW480 total CENP-A IP, and SW480
ectopic CENP-A IP. Gray graph indicates bulk octameric input, yellow
indicates recombinant nucleosomes, and blue and red indicate
tetrameric and octameric immunoprecipitation (IP) nucleosomes,
respectively. Dashed red line indicates average octameric height. Insets
contain mean ± standard deviation, and nucleosome count in each
sample. P values are provided to the right of each dataset compared.
Images show representative chromatin arrays, with arrowheads
indicating single nucleosomes (scale bar 100 nm, data summarized
in Table 3).
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A fractions associated with these transcription-coupled
chaperones.
These results outline three distinguishing characteristics
of the ‘high’ CENP-A state in human cells: increased associ-
ation of CENP-A with H3.3 chaperones ATRX and DAXX,
increased interaction of canonical H3 with ectopic CENP-
A, and an abundance of the ectopic CENP-A fraction.
Ectopic CENP-A nucleosomes have altered conformations
In vivo, CENP-A and H3 do not mix within single nucleo-
somes [37]. Given the association of ectopic CENP-A and
H3 above, we were curious whether such nucleosomes, or
their chromatin fibers, might present an alteration of
nucleosomal features. To this end, we turned to high-
resolution microscopy. In an extensive series of studies
using AFM coupled to other biochemical assays, we have
previously shown that in contrast to in vitro reconstituted
recombinant CENP-A nucleosomes, which are octameric
and generally indistinguishable from H3 nucleosomes
[38-41], CENP-A nucleosomes purified from native hu-
man centromeres from HeLa or HEK cells, display smaller
dimensions [42,43], and attain a stable octameric height
only at specific points of the human cell cycle [44]. There-
fore, we next used AFM to measure native nucleosomal
dimensions of ectopic versus centromeric and recombin-
ant CENP-A nucleosomes.
In agreement with previously published work, native
bulk nucleosomes observed on extracted chromatin
arrays are exclusively octameric, averaging 2.5 nm in
height (Figure 2, lowest panel, gray, AFM data summarized
in Table 3). Furthermore, in vitro reconstituted H3-
(Figure 2, second panel from bottom, yellow), or CENP-A-
nucleosomes (Figure 2, third panel from bottom, yellow),
which are octameric [38-41,45,46], both possess dimen-
sions essentially identical to bulk nucleosomes (dotted red
line denotes mean octameric values). In contrast, the
majority of total CENP-A nucleosomes in SW480 possess
diminutive dimensions, averaging 2.1 nm in height
(Figure 2, second panel from top, blue). However, upon
closer examination, we noted that total CENP-A nucle-
osomes from SW480 have a distinct second population,
with sizes reminiscent of the larger fraction of the stable
octameric state (Figure 2, second panel from top, right-
hand tail highlighted in red). Indeed, upon depleting
centromeric CENP-A nucleosomes using the CENP-B de-
pletion strategy above (Figure 1C), ectopic CENP-A nucleo-
somal arrays derived from SW480 cells display a broad
height distribution with an overall average slightly smaller
than bulk octamers (2.46 nm, Figure 2, top panel, red;
Table 3). This broader height distribution is most likely due
to partial contamination of the ectopic fraction with the
centromeric CENP-A nucleosomes originating from alpha
satellite arrays lacking CENP-B boxes, as mentioned above.These data indicate that two distinct populations of
CENP-A nucleosomes co-exist in colorectal cancer cells:
one that contains diminutive features similar to that pre-
viously reported from native centromeres, and another
that closely mimics the stable H3 or CENP-A octameric
nucleosome in vitro.
Ectopic CENP-A hotspots localize to DNase I hotspots and
transcription factor binding sites
We were curious to understand where ectopic CENP-A nu-
cleosomes such as those above (Figures 1E, F and 2) might
reside in the genome. Therefore, we amplified the nucleo-
somal DNA contained within SW480 CENP-B-associated
centromeric and ectopic CENP-A nucleosomes, and used











Heighta (nm) 2.53 ± 0.26 (401) 2.32 ± 0.32 (57) 2.37 ± 0.34 (57) 2.17 ± 0.35 (546) 2.46 ± 0.40 (135)
Diameterb (nm) 13.8 ± 1.4 (401) 12.1 ± 1.4 (20) 10.6 ± 1.4 (20) 14.1 ± 2.9 (546) 14.5 ± 3.0 (135)
AFM measurements of aheight and bdiameter data of ectopic versus centromeric or recombinant CENP-A nucleosomes provided as average ± standard deviation,
with number of particles measured indicated in parenthesis. On average, each type of experiment has three replicates.
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situ hybridization (co-FISH) experiment against human
metaphase chromosomes. As expected, CENP-B-associated
nucleosomal DNA (in green) hybridizes almost exclusively
to centromeres (Figure 3A). In contrast, ectopic CENP-A
nucleosomal DNA (in red) hybridizes to chromosome
arms (Figure 3A), illustrating the effectiveness of the
CENP-B depletion strategy. This interesting distribution
prompted us to generate a genome-wide map of ectopic
CENP-A nucleosome residency in the genome. In order
to achieve this, we performed high-throughput genome-
wide sequencing using exclusively the gel-purified
mono-nucleosomal fraction from thoroughly MNase
digested chromatin from Mock IP DNA, or ectopic
CENP-A nucleosomal DNA from normal colon, HeLa,
and SW480 lines. The mono-nucleosomal fraction was
first assessed using high-resolution Bio-Analyzer chips
(Figure 3B and C). Whereas, no detectable DNA could
be seen in the mock IP, centromeric CENP-A IPs from
either HeLa cells or SW480 cells, using the classical
anti-centromere antibody (ACA) (first used to identify
CENP-A in human cells by the Earnshaw lab, (39)),
yield two species: one at approximately 120 bp, and the
other at approximately 170 bp (Figure 3C-E). The
smaller species is consistent with previously published
data for centromeric CENP-A nucleosomes (24, 38,
40, 43 to 50). In contrast, ectopic CENP-A mono-
nucleosomes contain DNA fragments ranging from 125
to 164 bp of DNA (Figure 3B and D), greater than the
120 bp present in the CENP-A octameric crystal struc-
ture [39], or the 100-120 bp wrapping previously dem-
onstrated to exist in vivo for native centromeres of yeast
[47-49], Drosophila [42,50] or human cells [24,43,44].
As suggested by the AFM data above (Figure 2), these
DNA data support the possibility that ectopic CENP-A
nucleosomes contain distinctive structural features.
Sequencing of the mononucleosomal fraction obtained
from chromatin input samples from each cell line
confirmed equal and robust genomic representation
in the extracts, which were comparable to other ENCODE
data sets (Table 4). Reassuringly, mock IP ChIP-seq per-
formed to rule out potential background signal identi-
fied a very small number of weak background-related
hotspots (approximately 200). Furthermore, correlation
analyses of replicates for normal colon, HeLa, and
SW480 ectopic CENP-A ChIP-seq each demonstratedexcellent concordance, with an r2 > 0.9 for each set
of replicates (Figure 4A). From the pooled replicate
concordant data, we next determined statistically sig-
nificant, input-adjusted tags representing true ectopic
CENP-A ‘hotspots’ in the genome, at a stringent false
discovery rate (FDR) of 0.1%. This method yields a
robust view of CENP-A occupancy after accounting for
copy number variation often found in cancer genomes.
Contrary to our expectation that CENP-A would be
found exclusively at centromeres or heterochromatin,
ectopic CENP-A hotspots localize to noncentromeric
loci in normal colon, HeLa, and SW480 cells (Figure 4B,
left panel). Indeed, the main difference was the number
of hotspots found in each cell line, which generally cor-
responded to the overall level of CENP-A expression:
whereas in normal colon cells, there are approximately
450 ectopic CENP-A hotspots, in HeLa cells there is a
twofold increase to approximately 950, and in SW480
cells there is an almost sixfold increase over normal
colon to approximately 2,850 hotspots (Figure 4B, left
panel). These hotspots do not arise from background
signal, as only a tiny fraction of the mock IP-hotspots
correlated with any of the ectopic CENP-A hotspots
above (Figure 4B, left panel).
To investigate the nature of ectopic CENP-A hotspots,
we next classified them with respect to known genomic
and epigenetic features. Irrespective of the difference in
the total number of hotspots, a sizeable portion of ec-
topic CENP-A was found at gene loci, with 23%, 38%,
and 44% of ectopic hotspots at genes in HeLa, SW480,
and normal colon cells, respectively (Figure 4B, right
panel for histogram, and Additional file 1 contains the
dataset of all hotspots discovered). Thus, CENP-A
presence at genes seems to be a common feature, as it
was found in all cell lines examined, with a significant
fraction of those sites present at promoters of genes
(7%, 15%, and 34% in HeLa, SW480, and normal colon
cells, respectively). Indeed, CENP-A enrichment at pro-
moters is statistically significant in SW480 compared to
HeLa cells (Fisher’s exact test P value: 0.0174), suggesting
that colon cells tend to accumulate CENP-A at open chro-
matin regions (specific examples are shown in Figure 4C).
In the experiments above, we noted that the trans
cription-coupled chaperones ATRX and DAXX are overex-
pressed in SW480 cells (Figure 1A), whereas levels of
the CENP-A chaperone HJURP, which normally restricts
Figure 3 (See legend on next page.)
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Figure 3 Distribution and analysis of nucleosomal DNA associated with ectopic or total CENP-A immunoprecipitation. (A) Fluorescent
in situ hybridization showing location of the DNA isolated from CENP-B and ectopic CENP-A immunoprecipitations. DNA isolated from either
CENP-B (green) or ectopic CENP-A IP (red) was used to generate fluorescent in situ hybridization (FISH) probes and hybridized to metaphase
chromosomes. Chromosome indicated by white arrow is shown magnified in the right panel. Blue/grey - DAPI, scale bars: 5 μm (left panel) and
2 μm (right panel). (B) High-resolution Bio-Analyzer DNA chips show no detectable mononucleosomal DNA in Mock immunoprecipitation (IP)
and demonstrate that ectopic CENP-A nucleosome-associated DNA is octameric in size in normal colon, HeLa, and SW480 cells, ranging from
124 to 164 bp in length. (C) As above, indicating the size of nucleosome-associated DNA isolated from HeLa and SW480 cells by IP with
anti-centromere antibodies (ACA) serum. (D) High-resolution Bio-Analyzer analysis of mononucleosomal DNA values for input, ectopic CENP-A
nucleosomes (from Figure 1E) and centromere-specific CENP-A nucleosomes that were purified with ACA serum (from Panel E below). DNA
lengths below 350 bp were binned into four categories, and plotted by percentage of total fluorescence (pg/uL). (E) Two-color WB analysis of
CENP-A and H3 protein levels from HeLa and SW480 isolated by IP using ACA serum.
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did not correlate with increased CENP-A levels. We
wondered whether ectopic CENP-A accumulation at
promoters is linked to HJURP presence. Therefore,
we performed HJURP IPs from cross-linked chroma-
tin, using the CENP-B depletion strategy as above
(Figure 1C), followed by high throughput sequencing
analysis to unveil potential sites of ectopic HJURP
localization. We were unable to obtain robust ectopic
HJURP enrichment. Fewer than 300 HJURP hotspots
were detected in SW480 cells (Figure 4D, Additional
file 1 for list of HJURP hotspots). Although 36% of the
942 HeLa CENP-A hotspots correlate with HeLa
HJURP sites, only 5% of SW480 CENP-A hotspots co-
localize with SW480 HJURP sites (Figure 4D). Such
paucity of noncentromeric HJURP sites overlapping with
ectopic CENP-A sites in SW480 is consistent with
HJURP’s primary documented role as a centromere-
targeted chaperone, and would support the hypothesis
that overexpressed CENP-A can co-opt alternative
chaperone pathways to accumulate at genes, as has
recently been shown for forced overexpression of CENP-
A in human cells [24].
If CENP-A is indeed co-opting accessibility pathways
to accumulate at genes, we hypothesized that chroma-
tin accessibility might play a role in ectopic CENP-A
localization. To test this, we turned to the classical
DNase I nuclease hypersensitivity assay [53,54] com-
bined with high throughput deep sequencing [55] to
pinpoint with base-pair accuracy the locations ofTable 4 Genome coverage of chromatin input samples
from normal colon, HeLa, and SW480
Cell line Number of reads Percent genome coverage (%)
Normal colona 25623102 60.175
HeLa - rep 1a 15153407 35.693
HeLa - rep 2a 25383705 59.401
SW480 - rep 1a 17372957 37.986
SW480 - rep 2a 17092081 48.774
Chromatin input samplesa were analyzed by high-throughput sequencing
and aligned to reference human genome ‘hg19’. This data was used for
input-adjustment of chromatin immunoprecipitation (ChIP)-seq samples.transcription-factor bound chromatin in SW480 and
HeLa cells. (Normal colon cells were present in too low
density for us to reliably assess DHS sites in those
cells). To release hypersensitive chromatin, we per-
formed very light DNase I digestion of either SW480 or
HeLa nuclei following established protocols [56]. DHS
fragments (ranging from 50 to 350 bp) float on top of
sucrose gradients, separating them from the rest of the
longer DNAs, which originate from the chromatin-
bound fraction. Purified DHS fragments were then sub-
jected to deep sequencing (Figure 5A), thus generating
a genome-wide distribution map of DHS.
As expected, the vast majority of DHS enrich primarily
at promoters in HeLa and SW480 cells (Figure 5B, right
panel shows histograms, and Additional file 1 for a list of
DHS), and overlap completely with the compendium
of aggregated DHS clusters identified by the ENCODE
project for 129 human cell lines (Figure 5C). DHS
identified in our data sets included promoters of house-
keeping genes, oncogenes, and tumor suppressor genes
(Additional file 1 for list of all DHS, examples in
Figure 5D). For example, the Myc gene, a known regu-
lator atop a cascade of tumor effector proteins [57], has
a large DHS site astride its promoter in SW480 cells
(Figure 5D). Indeed, the gene encoding CENP-A itself
has a strong DHS site upstream of its promoter specif-
ically in SW480 cells but not in HeLa cells, providing a
satisfying correlation between increased accessibility of
the CENP-A gene promoter, and excess CENP-A
mRNA (and subsequently, protein) present in SW480
cells (Figure 5D).
When comparing DHS hotspots to ectopic CENP-A
sites, we observed that a large fraction of DHS tracks
with ectopic CENP-A locations (Figure 5B, left and
middle panels). Globally, about approximately 380 CENP-
A sites overlap with DHS sites in HeLa (Figure 5B, left
and middle panels), whereas twice that number, approxi-
mately 740 SW480 CENP-A hotspots align perfectly with
SW480 DHS.
A mechanistic question that arises from the correlation
between ectopic CENP-A and DHS, was whether ectopic
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Figure 4 Genome-wide analysis of ectopic CENP-A demonstrates enrichment of CENP-A hotspots at DNase I hypersensitive sites.
(A) Concordance analysis of chromatin immunoprecipitation (ChIP)-seq replicates of ectopic CENP-A IPs in normal colon, HeLa, and SW480 cells
displays r2 > 0.9, indicative of high reproducibility. (B) Left: distribution analysis of hotspots in normal, HeLa and SW480 cells; Venn diagrams of
hotspots from SW480, HeLa, or normal colon cells versus Mock immunoprecipitation (IP). Right: Genomic location of hotspots from left panel
shown as a percentage of total. Legend below indicates genomic location. Fisher’s exact test was performed for comparison of HeLa and SW480
histograms: P = 0.0174 (C) Genome browser snapshots of ectopic CENP-A localization depict representative examples of CENP-A and DHS hotspots at
genes overlapping with clusters of DNase I sensitivity, H3K27Acetylation and Transcription factor binding in the ENCODE data. Scale bars are in the
upper left corner of each snapshot. (D) Distribution of HJURP hotspots in HeLa and SW480 cells. Venn diagram demonstrates 30 to 40% of HJURP
hotspots overlap with ectopic CENP-A hotspots, but the number of HJURP hotspots in SW480 is very low.
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this end, we compared CENP-A hotspots to aggregated
genome-wide locations of DHS and transcription factor
binding sites from 129 and 94 cell lines respectively
(ENCODE project). From these comparisons it was
apparent that pre-existing DNase I and transcription
factor binding sites are striking determinants of ectopic
CENP-A localization (Table 5). Approximately half of
normal colon or SW480 CENP-A hotspots (61% and
45%, respectively) overlap with ENCODE DNase I clus-
ters; and a majority of normal colon and SW480 CENP-
A hotspots (63% and 48%, respectively) overlap with
transcription factor binding clusters found in a variety
of cells (Table 5). This increase in overlap between
SW480 CENP-A hotspots and our DHS analysis, com-
pared to the ENCODE DHS data (from 26% to 45%),
indicates that CENP-A can also localize to transient
hypersensitive sites, which were not detected in our ex-
periments but were captured in the vast compendium
of DHS sites in the ENCODE data.
We were curious whether ectopic CENP-A locations
had DNA sequence-specific features that might yield
insights into what attracts CENP-A to them. Using the
DNA consensus detection algorithm TOMTOM to detect
motifs common amongst CENP-A hotspots, we discov-
ered that CENP-A enriched sequences are not AT-rich,
nor do they contain centromere-like repetitive DNA. In-
deed, fewer than 20% of the hotspots contain Alu, LINE
or SINE elements, and less than 0.01% of the hotspots
contained centromeric consensus alpha satellite se-
quences (Table 6), suggesting the CENP-B depletion
strategy was effective. Whether from normal colon,
HeLa, or SW480, ectopic CENP-A hotspots contain
CpG motifs (Figure 6A-B), and motifs associated with
transcription factors, especially those of the zinc-finger
and helix-turn-helix classes (Figure 6B-C). Together,
the DHS and DNA motif data suggest that ectopic
CENP-A accumulates at regions of high nucleosome
turnover in the genome.
Ectopic CENP-A nucleosomes cluster at subtelomeric sites,
including 8q24/Myc, in colorectal cancer cells and tumors
In the genome-wide map of all CENP-A hotspots identified
in this study, we noted a qualitative clustering of CENP-Ahotspots in subtelomeric and pericentromeric regions
(Figure 7 shows all chromosomes, Figure 8A focuses on
one example, grey boxes denote clusters). Such regions
have been previously associated with chromosomal break-
points and translocations [58]. We chose one of these
domains involving the cytoband 8q24 for further analysis,
as it represents one of the most frequently rearranged
regions in the cancer genome of many carcinomas and
hematological malignancies [59,60]. Furthermore, this
region has long been associated with tumorigenesis
[61,62], and with chromosome instability [63]. From
previously published cytogenetic SKY/CGH maps, it is
known that the 8q24/Myc locus is amplified and trans-
locates to multiple chromosome partners in SW480
cells but not in normal colon cells [64].
The deep sequencing data uncovered a 30 MB region
of CENP-A and DHS co-enrichment on the 8q24/Myc
locus in SW480, but not HeLa or normal cells. This
enrichment was apparent even after correcting for copy
number amplification of this locus (Figure 8B, see
input-adjusted hotspots below the tag density tracks).
This result was surprising, because although this region
has been extensively studied, there are no extant reports
of it containing unusual histone variants. Furthermore,
large domains of CENP-A usually exist only in active
centromeres, wherein they attract inner kinetochore
proteins such as CENP-C, which connect CENP-A to
the outer kinetochore during mitosis [65]. We tested
whether CENP-C was enriched in the 8q24 region.
Using CENP-A and CENP-C ChIP followed by quanti-
tative PCR (qtPCR) for probes spanning this 30 MB
locus (primer locations indicated in Figure 8A), we
observed robust enrichment of both CENP-A and
CENP-C within the domain spanning the 8q24 locus
(Figure 8C, qtPCR graph). We reasoned that a CENP-
A/CENP-C domain spanning 30 MB should be visible
by immunofluorescence. Therefore, we used a combin-
ation of 8q24-FISH and CENP-A-IF to visualize this
region. To ensure the accuracy of detection, we first
tested the 8q24 FISH probe on metaphase spreads from
normal human lymphocytes. As expected, we observed
two discrete subtelomeric signals per chromosome, for
a total of 4 N per mitotic cell (Figure 8D, upper left
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Figure 5 DNase I hypersensitive sites (DHS) are enriched at promoters of oncogenes and tumor suppressor loci in the colorectal
cancer genome. (A) Sucrose gradient purification of DHS fragments resolved on High-resolution Bio-Anaylzer gels before deep sequencing.
(B) Left: distribution analysis and overlap between HeLa DHS and HeLa CENP-A; and SW480 DHS and SW480 CENP-A. Right: Genomic locations of
CENP-A hotspots coinciding with DHS shown as a percentage of total, color-coded as in (B). (C) DHS identified in this study wholly belong to the
large compendium of DHS identified by ENCODE in 129 cell lines. (D) Examples of DHS profiles for individual genes demonstrate that the promoters
of some oncogenes are preferentially accessible in SW480 cancer cells. The gene for CENP-A itself has an increased DHS peak over its promoter in
SW80 cells, correlating with increase in mRNA and protein levels for CENP-A in SW480 cells.
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for this locus. Co-FISH for 8q24 and the native centro-
mere 8 demonstrates one set of 8q24 signals originating
from a subtelomeric location on chromosome 8, as well
as a number of additional signals emanating from
translocated sites (Figure 8C, upper right panel).
Using a combination of either 8q24 FISH and CENP-A
IF, or Myc FISH and CENP-A IF, we next tested whether
CENP-A co-localizes to any of the signals of 8q24 in nor-
mal colon, HeLa, and SW480 cells. No correlation between
8q24 and CENP-A signals can be seen in normal colon,
and very little can be seen in HeLa cells (Figure 8C-D,
three lower left panels). In contrast, 8q24 co-localizes
to a distinct CENP-A domain in 38-66% of SW480
cells, when using either the 8q24 or Myc probes,
respectively (Figure 8C, middle left panel, white arrows
point to co-localized signals; Figure 8D, lower right
panels; data are quantified in Table 7). Thus, in the
colorectal cancer cell line possessing the highest amount
of CENP-A protein (Figure 1A), CENP-A localizes to 8q24
in a large fraction of cells. Consistent with the qtPCR data
(Figure 8C, first panel), CENP-C IF combined with 8q24
FISH demonstrates enrichment of CENP-C on one 8q24
locus (Figure 8C, middle right panel).
We were intrigued by the presence of CENP-A/CENP-
C at the 8q24 locus in the SW480 colorectal cancer
SW480 cell line, which was derived from a late stage
colorectal tumor nearly 30 years ago [64]. We sought to
understand how early in tumorigenesis CENP-A might
mislocalize to 8q24. We acquired primary early and late
stage colorectal tumors, as well as matched normal tis-
sue from the same patients, and performed FISH/IF to
test co-localization of CENP-A to 8q24. The co-IF/FISH
data show that the 8q24/Myc locus is amplified in all
four tumors, and that CENP-A domains are enriched on
one of these 8q24 loci ranging from 33 to 78% of tumorTable 5 Ectopic CENP-A is enriched at DNase I hypersensitive
CENP-A hotspotsa Normal colon %
DNase clustersb 273 60.80
Txn Factor ChIPc 285 63.47
Comparative analysis of aCENP-A hotspots derived from normal colon, HeLa and SW
sites overlap with ENCODE bDNase I clusters and ctranscription factor binding sites
of total CENP-A sites.cells, depending on the donor (Figure 8C, lowest set of
panels for representative images of normal versus tumor,
white arrow points to co-localization, quantification in
Table 7). Thus, CENP-A occupancy of this locus is
robust and occurs even in early stage tumors.
Discussion
In this report, we present a comprehensive examination
of the histone variant CENP-A in colorectal normal and
cancer cells, finding that ectopic CENP-A exists outside
centromeres in human cells. Ectopic CENP-A tracks to
two distinct types of domains: small regions found at
promoters and accessible chromatin; and large domains
found at sites of common chromosomal rearrangements.
Our report yields a number of specific findings. First,
CENP-A, which is innately overexpressed in cancer
cells (Figure 1A-B, Table 1), associates with histone H3
(Figure 1E, Table 2), and shows increased association
with transcription-coupled chaperones DAXX and ATRX
(Figure 1F, Table 2). Second, ectopic CENP-A nucleo-
somes are stable octamers in configuration (Figure 2,
Table 3), containing 125 to 165 bp of DNA (Figure 3B-D).
Third, ectopic CENP-A nucleosomal tags are depleted in
centromeric consensus satellite sequences (Table 6), and
localize instead to unique noncentromeric locations in
normal and cancer cell lines (Figure 3A). These nucleo-
somes occupy genes and promoters (Figure 4B-C), are
HJURP-free (Figure 4D), and correlate primarily with
hyper-accessible (DHS) chromatin (Figure 5, Table 5).
Fourth, CENP-A/DHS ectopic sites co-occupy regions
containing known transcription factor binding motifs
(Figure 6, Table 5). Lastly, large clusters of CENP-A
hotspots exist in regions spanning pericentric and sub-
telomeric regions specifically in colorectal cancer cells
(Figures 7 and 8, Table 7). An example of such a cluster
is at a segment of the 8q24 locus spanning the Myc(DHS) sites and transcription factor binding sites
HeLa % SW480 %
247 26.22 1292 45.44
255 27.07 1361 47.87
480 cells compared to ENCODE data aggregates reveal a significant fraction of
in the genome. Each column shows overlap in terms of number of sites or %
Table 6 Analysis of total sequence tags obtained from normal colon, HeLa and SW480 CENP-A immunoprecipitations
(IPs) demonstrates they are not enriched in repetitive elements
Tagsa Normal colon % HeLa % SW480 %
Alu 334960 0.65 226475 0.65 216285 0.63
LINE 10749901 20.81 6808429 19.52 6340827 18.53
SINE 1034138 2.00 711621 2.04 700002 2.05
Centromeric α-satellite 633 0.001 1163 0.003 3871 0.011
# total tags 51651054 100.00 34875940 100.00 34212787 100.00
Note: aAll sequences tags were extended to the length of 150 bp by strands to calculate overlapping.
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tested in this study, associates with CENP-A and
CENP-C (Figure 8B-D, Table 7).
A number of avenues of investigation arise from our
observations. Regardless of the absolute amount of
ectopic CENP-A, in normal colon cells, and in the cancer
cell lines examined, there is a connection between DHS/
transcription factor binding sites and ectopic CENP-A
(Figures 5 and 6). That CENP-A can compete for regions
linked to transcription was initially demonstrated in
budding yeast, wherein CENP-A is reported to exist at
barely detectable levels in a handful of genic promoters
[49], which increases when CENP-A is artificially overex-
pressed [48]. Such CENP-A is continually targeted for
subsequent proteolysis [23,52]. Earlier work has also dem-
onstrated that artificial constitutive overexpression of
CENP-A in Drosophila cells results in a gradual accumula-
tion and slow removal of CENP-A from chromosome arms
[22], possibly via association with the common histone
chaperone RbAp48/p55 [66]. In vitro, common chaperones
such as p55 and NAP-1 assemble CENP-A nucleosomes
efficiently [41,66]. However, generally it has not been
thought that such phenomena could occur in human cells,
with many laboratories publishing studies using tagged/
overexpressed CENP-A as a marker for human centro-
meres. However, a recent report tracking artificially overex-
pressed human CENP-A has demonstrated that it can
occupy ectopic sites, binds histone H3.3, contains octa-
meric size DNA fragments, and is potentially chaperoned
by ATRX and DAXX [24]. Indeed, in worms, which form
holocentric centromeres that line the edges of chromo-
somes, normal amounts of CENP-A seed centromeric
domains using regions of low nucleosome turnover [67].
Our report demonstrates that a subset of native human
CENP-A binds H3, forms octameric height nucleosomes,
which localize to accessible chromatin domains at pro-
moters and transcription factor sites at low levels even
in normal human colon cells. This process appears
to be magnified in amplitude in colorectal cancer cell
lines, where a significant fraction of ectopic CENP-A
nucleosomes overlap with DHS and transcription factor
binding sites (Figure 5 and 6). It is feasible that a default
transcription-linked pathway exists to use trace amountsof CENP-A either promiscuously expressed at the wrong
time (that is, not at the end of G2 [68]), or remnant
after HJURP-dependent incorporation at centromeres is
complete at mid-G1 [69]. Not mutually exclusive to this
explanation is the interesting possibility that defects
in the timing of CENP-A expression, or promiscuous
binding of CENP-A to other chaperones, coupled to de-
fects in proteolysis, might cumulatively conspire to per-
mit increased CENP-A accumulation at transcription
factor binding sites in cells.
Conclusions
A functional implication of stable CENP-A occupancy
of promoters/DHS and its correlation with transcription
factor binding sites is the potential link to gene ex-
pression changes reported in cancer cells. It is currently
unknown if CENP-A is recruited by, or competes for
transcription factor binding sites, either of which would
be predicted to impact gene expression. Indeed, the
DHS data demonstrate that many of the sites that at-
tract CENP-A are already DHS and transcription factor
binding sites, that is, high nucleosome turnover regions
in a number of human cell lines. At the vast majority of
genes in vivo, octameric H3 nucleosomes, with specific
N-terminal tail modifications, dominate the epigenetic
regulatory landscape [70]. Ectopic CENP-A nucleo-
somes would lack known H3 N-terminal tail modifica-
tions, and could potentially circumvent traditional
epigenetic regulatory cascades. Thus, the functional
impact of CENP-A nucleosomes on pre-existing DHS
sites, or on promoter architecture, remains an exciting
avenue of research. Ongoing studies are focused on
whether recruitment of transcriptional activator or re-
pressor complexes is altered in the presence of ectopic
CENP-A nucleosomes, and whether such events influ-
ence gene expression patterns specifically in the cancer
context.
Our study also provides support for a potential role for
CENP-A in chromosomal instability. Whereas various
artificial overexpression studies over the past decade have
clearly established CENP-A’s ability to seed neocentro-
meres [17], this study provides a correlation between
CENP-A and a defined chromosomal rearrangement at
Figure 6 DNA analysis of ectopic CENP-A hotspots demonstrates enrichment of CpG density and transcription factor binding motifs.
(A) Ectopic CENP-A associated DNA is moderately enriched in CpG motifs. Window shows CpG motifs enriched in a scanning 10 bp window from
an overlay of all hotspots (B) Left: TOMTOM DNA Motif analysis of CENP-A hotspots in SW480 and HeLa cells. Right: Pie charts showing similarity
of identified hotspots to known classes of transcription factor binding sites. Detailed data for analysis of hotspots can be found in Table 5.
Additional file 1 contains the full list of hotspots, and a genome-wide overview is in Figure 7. (C) A list of other TOMTOM consensus motifs
that correlate to the motifs identified in CENP-A hotspots includes chromatin effector proteins.
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colon cells (Figure 8, Table 7). When normal human ES
cells are challenged by induced DNA breaks, excess
native CENP-A is rapidly mobilized, but does not
localize to immediate break sites indicated by gamma-
H2A.X staining [71]. However, a recent study used
osteosarcoma-derived U2OS cancer cells, in which anartificially induced break was shown to efficiently
recruit overexpressed CENP-A:GFP [72]. Thus, de-
pending on the timing of the break, and availability of
free histones, CENP-A might enrich during subsequent
steps of chromatin re-establishment following repair
or translocations of amplified regions in cancer cells.
An avenue of research that arises from these findings
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Figure 7 Genome-wide distribution of ectopic CENP-A hotspots across human chromosomes. Ectopic CENP-A clusters (gray boxes) at
pericentromeric and subtelomeric regions of most human chromosomes in SW480, but not in HeLa or normal colon cells.
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breakpoints during tumorigenesis, and investigating its
potential role in structural rearrangements of chromo-
somes in subtelomeric sites such as 8q24.Increased levels of CENP-A expression have been
reported in metastatic prostate, breast, lymphoma, lung
and colorectal tumors. Consequently, our observations,
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Figure 8 Ectopic CENP-A clusters at a large domain at the subtelomeric 8q24/Myc locus in colorectal cancer cells and tumors. (A) CENP-A
hotspots cluster (indicated by gray boxes, additional examples in Figure 7) at subtelomeric regions of chromosome 8 in SW480 cells, but not in normal
colon cells. (B) Chromatin immunoprecipitation (ChIP)-seq profiles (tag density peaks) and input-adjusted hotspot analysis (vertical bars below each
profile) demonstrate CENP-A distribution relative to input chromatin upon the 30 MB domain spanning the cytogenetic band 8q24 in SW480, HeLa,
and normal colon cells (note that input tag density peaks reflect increased copy number of this region in SW480 cells, but hotspot analysis takes into
account copy number variation). Base numbers above indicate the genomic location, and horizontal lines below the genome browser profile indicate
position of fluorescent in situ hybridization (FISH) probes used for FISH/co-IF in (C). (C) Upper left panel: qtPCR graph demonstrating CENP-A and
CENP-C enrichment at the 8q24 locus in SW480 cells (positions of PCR primers are indicated in (A), negative control (NC) primers were selected from
chromosomes 1 and 11 from regions with no CENP-A peaks based on ChIP-seq data). Upper right panel contains cytological analysis of metaphase
chromosome spreads stained with FISH probe for 8q24 (in green), indicating amplification of this region in SW480 cells. One of these translocated
8q24 loci (green) associates with CENP-A (red) (middle left panel) and the inner kinetochore protein CENP-C (red) (middle right panel). Combining FISH
and IF in three primary colon tumors demonstrates that CENP-A (red) co-localizes with one of the amplified regions of 8q24/Myc (green) in the tumor
(right bottom panel) but not in normal tissue (left bottom panel). White insets and arrowheads point to co-localization spots detected by Image J
automated co-localization algorithm. Quantification is provided in Table 7. (D) Additional controls for the FISH/IF experiments in (C). First panel depicts
FISH of 8q24 to metaphase spreads of normal human lymphocytes, demonstrating specific hybridization to 2 subtelomeric locations. Second panel
depicts Co-IF/FISH of native centromere 8 and CENP-A on metaphase chromosome spreads in SW480 cells demonstrating that native centromere 8
still contains CENP-A and is active. Remaining panels demonstrate that CENP-A co-localizes to one of the amplified and translocated regions
of 8q24/Myc in SW480 cells (right panels), but not in HeLa (left panels) cells. Quantification of this data is presented in Table 7. Merge of DAPI
(blue or gray), 8q24 or Myc (green) and CENP-A (red) is indicated for each cell line at the top of each image. Automated co-localization analysis was
performed using Image J; white is indicative of co-localization shown as insets.
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[24,73], have implications for accumulation of down-
stream epigenetic defects that arise during tumorigenesis.Methods
Cell culture
All cell culture medium except epithelial cell medium
was supplemented with 10% fetal bovine serum and 1X
penicillin and streptomycin. Cell culture media DMEM
was used for HeLa cells, RPMI for SW480 and DLD1,
and McCoy’s media for HCT116 and HT29. Epithelial
cell medium was used to culture normal human colon
epithelial cell (HcoEpiC). HcoEpiC cells are very slow
growing, with the cell cycle lengths ranging from 36 to
90 hours depending on passage number.Table 7 CENP-A is enriched at the 8q24/Myc locus in tumor-d
Cell line/tumor Probe
Cell Line HeLa Myc
Cell Line SW480 Myc
Cell Line Normal Colon 8q24
Cell Line HeLa 8q24
Cell Line SW480 8q24
Tissue Normal 8q24
Tissue Tumor 1 8q24
Tissue Tumor2 8q24
Tissue Tumor 3 8q24
Tissue Tumor 4 8q24
aQuantification of CENP-A and 8q24/Myc co-localization in cancer cells and tumors
enrichment of CENP-A occurs on one of the translocated 8q24/Myc loci. White spot
co-localization algorithm.Total nuclear proteins extraction
Nuclei were purified from cell lines: HcoEpiC, HeLa,
HCT116, DLD1, HT29 and SW480 following published
procedure [43,44]. Total nuclear proteins extracts were
prepared in RIPA-Buffer. Equal amount of nuclear pro-
teins were fractioned on SDS page gels, stained and ana-
lyzed on Odyssey and amounts were adjusted to equal
amount of histone H4 for further analysis. Samples con-
taining equal amount of histone H4 were fractioned on
SDS page gel and the amounts of CENP-A, HJURP,
ATRX, DAXX and histone H4 were determined by
quantitative western blot analysis. Relative concentration
of CENP-A in different cell lines was calculated as ratio
CENP-A/H4 in a cell line divided by ratio of CENP-A/
H4 in normal colon cells. Relative concentrations of
ATRX, DAXX, and HJURP were calculated similarly.erived SW480 cells and in human tumors











after co-immunofluorescence demonstrates that a statistically significant
s denoting co-localization were detected using Image J’s automated
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Quantitative infrared western blotting was performed
using Odyssey Li-Cor CLx system (Lincoln, NE, USA).
Briefly, infrared western blot (WB) signal was acquired
with high dynamic range and analyzed using Image Studio
software. Bands of interest were manually selected and
their total intensity quantified with subtraction of median
background signal from an area 3-pixels wide above and
below the band in the same lane. The resulting total infra-
red signal values (arbitrary unit) were used for subsequent
calculations as indicated.
Chromatin immunoprecipitation
CENP-A, and CENP-B chromatin immunoprecipitation
(ChIP) for WB analysis was performed following pub-
lished protocol [43,44]. Briefly, cells were harvested,
washed with PBS once, PBS containing 0.1% Tween 20
three times and nuclei were released with TM2 buffer
(20 mM Tris-HCl, pH 8.0; 2 mM MgCl2) containing
0.5% Nonidet P40 (Sigma) and 0.5 mM PMSF. The nu-
clei were washed with TM2 buffer to remove detergent
once. To release chromatin, nuclei were digested with
0.3 U/ml MNase (Sigma) for 8 mins and reaction was
stopped with the addition of 10 mM EGTA. Nuclei were
extracted in low salt buffer (0.5X PBS containing 5 mM
EGTA and 0.5 mM PMSF) over night at 4°C. Chromatin
IP was performed using Dynabeads-protein G (Life
Technologies, Grand Island, NY, USA), Agarose protein
A/G plus (Santa Cruz, Santa Cruz, CA, USA) or protein
G sepharose 4 Fast flow (GE Healthcare, Laurel, MD,
USA) and antibodies listed below.
Antibodies used for chromatin immunoprecipitation,
western blot, and immunofluorescence
CENP-A: rabbit CENP-A (Santa Cruz; SC-22787, Santa
Cruz, CA, USA); rabbit CENP-A (Millipore; 07-574, Billerica,
MA, USA), custom CENP-A (CSEM laboratory); mouse
CENP-A (Abcam, ab13939, Cambridge, MA, USA); goat
CENP-A (Santa Cruz, sc-11277). HJURP: rabbit HJURP
(Bethyl, A302-822A, Montgomery, TX, USA). H2A.Z: rabbit
H2A.Z (Abcam, ab4174). CENP-C: goat CENP-C (Santa
Cruz, sc11285). CENP-B: rabbit CENP-B (Santa Cruz,
sc-22788), rabbit CENP-B (abcam, ac25743). ACA
serum (Centromere Ab Positive Serum) BBI Solutions
(Cat #SG140-2, Lot #3284-146-2, Cardiff, UK).
Chromatin IP for CHIP-Seq was performed similarly
as above, except for the following modifications: MNase
concentration was 0.6U/ml, digestion time was 10 min
for cancer cells and 8 min for normal HcoEpiC cells,
and nuclei were treated with 0.05 to 0.1% formaldehyde
for gentle in situ crosslinking within intact nuclei for 30
min at RT, as indicated in ENCODE protocols, before
extraction of chromatin in low salt buffer. IP-enriched
chromatin was eluted with 100 mM NaHCO3 and 1%SDS at 65°C for 2 h. To reverse cross-linking, NaCl was
added to the final 200 mM concentration and incubated at
67°C for additional 4 h followed by RNase A (150 μg/ml)
treatment for 1 h and then proteins were digested with
proteinase K (100 μg/ml) for 3 h. The DNA was puri-
fied by phenol extraction and ethanol precipitated. The
DNA was repaired using PreCR Repair mix (New England
Biolabs, Ipswich, MA, USA) following manufacturer’s in-
structions. DNA was purified using Chroma Spin columns
(Clontech, Mountain View, CA, USA).Nucleosome reconstitution in vitro
Lyophilized recombinant histones (a gift from Jennifer
Ottesen) were unfolded in 7 M guanidinium HCl, mixed
in equimolar amounts (Either H3 or CENP-A and one
each H2A, H2B, H4), and refolded into 2 M NaCl
according to the protocol by Luger et al. [74]. Refolded
nucleosomes were reconstituted onto a plasmid contain-
ing a ‘Widom 601’ positioning sequence (a gift from Carl
Wu) using sequential salt dialysis adapted for low
volumes. Briefly, histone octamers were mixed with plas-
mid DNA at 0.9:1 ratio in 2 M NaCl, 10 mM Tris-Cl
pH = 8.0, 1 mM EDTA (0.18 mg/ml histones; 0.2 mg/ml
DNA) and incubated on ice for 30 min. Next, 40 ul of his-
tone/DNA mix was layered onto a dialysis disc (Millipore,
0.025um, Billerica, MA, USA) covered with a dialysis
membrane (Thermo Scientific, 7000 MWCO, Waltham,
MA, USA) and floated on the surface of 50 ml pre-chilled
1 M NaCl, 10 mM Tris-Cl pH = 8.0, 1 mM EDTA buffer.
Sequential dialysis steps against 1 M, 0.8 M, 0.6 M, and
0.15 M NaCl (each with 10 mM Tris-Cl pH = 8.0, 1 mM
EDTA) were carried out for 2 hours at 4°C (0.6 M dialysis
was done overnight). Reconstituted chromatin was diluted
one hundredfold in 1X PBS, 2 mM MgCl2 buffer and im-
aged on AP-mica [75].Atomic force microscopy imaging and analysis
AFM imaging of bulk and immunoprecipitated CENP-A
chromatin was performed essentially as described previously
[43,44] with some adaptations (see manual analysis
below). Extracted or IP-eluted chromatin was deposited
on APS-mica (prepared as described by Dimitriadis et al.,
2010 [43]) in the presence of divalent magnesium ions.
The sample was incubated for 10 minutes, briefly rinsed
with MilliQ water, and dried in a vacuum chamber. The
sample was imaged using AFM 5500 (Agilent Technolo-
gies, now Keysight Technologies, Santa Clara, CA, USA)
operating in AC mode (noncontact/tapping), equipped
with either OTESPA or TESP silicone tip (Bruker Nano,
Santa Barbara, CA, USA) with a nominal radius of 3 to 7
nm. Images were captured at 4096x4096 resolution with
an instrument operating at setpoint equivalent to 65% to
75% of free amplitude (typically 1.5 to 2.5 V).
Athwal et al. Epigenetics & Chromatin 2015, 8:2 Page 19 of 23
http://www.epigeneticsandchromatin.com/content/8/1/2Acquired images were processed using Gwyddion
(gwyddion.net) software (flattening, line correction, and
polynomial background subtraction) and analyzed either
manually (see below), or, for bulk controls, using NIH
Image J software (imagej.nih.gov/ij/) Particle Analysis
function. Briefly, the images were limited by threshold (to
remove tip convolution) and filtered to include only round
or elliptical shapes. Max. height, total area, and volume
information was collected. SigmaPlot software was used
to statistically analyze the data and generate graphs. For
ectopic and recombinant CENP-A and H3 nucleosomes,
manual measurements were performed in Gwyddion soft-
ware to ensure that strictly DNA-associated particles were
included (diameter cutoff <20 nm).
BioAnalyzer analysis of DNA fragments obtained from
chromatin immunofluorescence
DNA samples were prepared according to manufac-
turer’s recommendations and ran on High Sensitivity
DNA Chips (Agilent Cat #5067-4626, Wilmington, DE,
USA) on the Agilent 2100 BioAnalyzer system. Data
with the control lower and upper limits were automa-
tically called or manually aligned (see figure) with the
Agilent 2100 Expert Software.
DNase I digestion of chromatin from HeLa and SW480
HeLa and SW480 cells were harvested with trypsin,
washed twice with ice cold PBS containing 0.1% Tween
20, and resuspend in low sucrose buffer (15 mM Tris-
HCl, PH 8.0, 15 mM NaCl, 60 mM KCl, 1 mM EDTA,
0.5 mM EGTA, 1 mM spermidine, EDTA free protease
inhibitors). Cells were mixed (1:1) with same buffer con-
taining 0.04% NP-40 and nuclei were released at 4°C.
Nuclei were harvested by centrifugation, washed with
low sucrose buffer and DNase I digestion was per-
formed with 20 million nuclei as previously described
[76,77]. DNA fragments of 100 to 500 bp from a chro-
matin digestion with 60 U/ml DNase I (Sigma, St. Louis,
MO, USA) were purified using sucrose gradient [77]
and DNA was precipitated in 0.1 volume of sodium
acetate and 0.7 volume of isopropanol.
Bioinformatic analysis of chromatin immunoprecipitation-
seq, DNase-seq, and TOMTOM DNA motif enrichment
Purified DNA from ChIP or DNase I digested chroma-
tin were used to prepare libraries for Illumina high-
throughput sequencing as described in manufacturer’s
protocol (Illumina Sequencing, San Diego, CA, USA).
Libraries were sequenced to generate 35 bp single end
reads using Illumina GAII sequencer at the Advanced
Technology Center, NCI (Frederick, MD). Sequence
reads were mapped to the reference genome hg19 by
the CASAVA 1.8.2 pipeline.Hotspot detection for DNase-seq
We identified regions of local enrichment of sequence tags
using a hotspot detection algorithm essentially as previously
described [55,77] with a false discovery rate (FDR) of 0.1%.
Hotspot detection and input adjustment for chromatin
immunoprecipitation-seq
The hotspot detection algorithm was similarly applied to
ChIP-seq data with the following modification. The sequen-
cing data from matching input samples are used for the
processing of ChIP data, as a measure of background signal
that might be significant. After normalizing the input data
to match the number of tags in the ChIP data, the number
of input tags is subtracted from the number of ChIP tags in
the target window before calculating its z-score.
DNA Motif discovery analysis
A motif discovery analysis on selected DNA sequences was
performed using MEME [78] on a parallel cluster at the
NIH Biowulf supercomputing facility (meme.nbcr.net/).
DNA sequences for MEME input were from the top 2000
(by tag density) hotspots. To limit the computational load,
only the 200-bp regions with the highest tag density were
used instead of the entire width of hotspots in cases where
the hotspots spanned greater than 200 bp. The width of
motif for searching was set to 6 and 20 for minimum
and maximum, respectively. To identify binding motifs
for known transcription factors, we queried individual
position-specific matrices against the Transfac data-
base using the Tomtom software (http://meme.nbcr.
net/meme/cgi-bin/tomtom.cgi). We retrieved statisti-
cally significant matches that share the majority of spe-
cific nucleotides in the sequence motifs.
Quantitative PCR analysis
Quantitative (real time) PCR was performed using the
IQ-Sybr Green Supermix kit from BioRad (#170-8880,
Hercules, CA, USA) in 25 μl reaction according to the
manufacturer’s protocol and samples were amplified
using I-cycler fitted with MyIQ Single color real time
PCR detection system (BioRad, Hercules, CA, USA). In
all experiments no template- and Mock IP (normal IgG
IP; negative control) controls, and input chromatin
DNA and IP samples (CENP-A & CENP-C) were in-
cluded from same experiment. The qtPCR reactions
were setup in triplicate thus giving three threshold
cycle numbers (Ct) for each sample. Experiment was
repeated three separate times. Enrichments and fold
changes were calculated as follows:
Ct.i = average Ct of input
Ct.m = average Ct of mock IP
Ct.IP = average Ct of IP samples (CENP-A and CENP-C)
STDV.i = standard deviation of input
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Step 1. Calculate ΔCt and STDV ΔCt for CENP-A,
CENP-C and Mock IP using the following
formulas:
ΔCt ¼ Ct:i–Ct:IP CENP−A;CENP−C or Mockð Þ
STDVΔCt ¼ SQRT STDVið Þ2 þ STDVIPð Þ2 =SQRT 2ð Þ
Step 2. Transform ΔCt and STDV ΔCt (with respect to
input) to input to linear scale fold change (FC)
and fold change error (E) as follows:
FCIP ¼ 2^ΔCt
E ¼ Log 2ð Þ  FC  STDVΔCt
Step 3 Fold Enrichment = FC of IP/ FC of Mock IP ± E
Identification and labeling of fluorescent in situ
hybridization probe for 8q24/Myc
Five overlapping bacterial artificial chromosomes (BAC)
containing human chromosome 8q24 region (chr 8:
125,771,341-127,401,859) and a larger region spanning
8q24/Myc (location of both probes are depicted on
Figure 8B) were selected and obtained from commercial
source (Invitrogen, Grand Island, NY, USA). DNA was
isolated from each BAC and labeled with biotin-dUTP
and hybridized to normal blood lymphocytes metaphase-
spread slides. Each BAC was evaluated for intensity and
specificity of hybridization at target region. The BAC
named RP11-150 N13 was selected to be used as a probe
for 8q24 (chr 8:126,377,028 to 126,556,325), and a previ-
ously published Myc probe was used to confirm the results
[79]. For probes, 2 μg BAC DNA was labeled with biotin-
dUTP by nick translation in the presence of 4 nmol/L la-
beled nucleotide. Approximately 100 to 200 ng of labeled
BAC probe was ethanol precipitated in the presence of 20
μg each salmon sperm DNA and human Cot1 DNA. The
dry pellet was dissolved in 5 to 6 μl of hybridization buffer.
The hybridization buffer contained 50% deionized form-
amide, 20% dextran sulfate and 4X SSC. The probe was
denatured for 5 min at 80°C and then pre-annealed for 1 h
at 37°C before adding to the slides for hybridization.
Co-immunofluorescence and fluorescent in situ
hybridization experiments
The IF on metaphase chromosomes, interphase cells from
cell lines and tumor-normal patient sample cells, was per-
formed on unfixed cells following published protocol with
some modifications [80,81]. Enrichment of mitotic cells
was achieved by double thymidine block to arrest cells
in G1 phase of cells cycle. Actively growing culture was
treated 5 mM thymidine for 18 to 20 h. The cells werereleased from first block and grown in fresh medium for
10 h followed by second block with 5 mM thymidine for
12 h. Cells were released from second block and cultured
further in fresh medium for 9 h. These cells were either
harvested to make slides or treated with 100 μg/ml colce-
mid (Roche, Indianapolis, IN, USA) for 1 h to make meta-
phase chromosomes and then harvested to make slides.
The cells were harvested with trypsin and washed with
PBS, resuspended in 75 mM KCl, and incubated at 37°C
for 13 min and then placed on ice. Cells were cytospun
onto glass slides for 5 min at 600 rpm. After air drying,
the slides were incubated in freshly prepared KCM buffer
(120 mM KCl, 20 mM NaCl, 10 mM Tris-HCl, pH 8.0,
0.5 mM EDTA) containing 0.1% Triton X-100 and prote-
ase inhibitors (1 μg/ml aprotinin, pepstatin A, Leupeptin
and antipain each) for 15 min at room temperature (RT)
followed by blocking (KCM buffer containing 3% BSA,
protease inhibitors and 1:100 dilution normal IgG) for 30
min and primary antibody (KCM buffer containing 1%
BSA, protease inhibitors and 1:100 dilution normal IgG)
for 1 h. The slides were washed with KCM three times 5
min each at RT followed by secondary antibody staining
for 1 h at RT. The slides were washed with KCM buffer
four times 5 min each at RT, fixed with 10% buffered for-
malin for 10 min at RT, washed with H2O three times 5
min each at RT, incubated in carnoy’s fixture for 30 min at
RT followed by dehydration in ethanol series (70, 95 and
100% ethanol) 5 min each and air dried.
For FISH, slides were equilibrated in 2X SSC for 5 min
and digested with pepsin (10 μg/ ml) for 3 min at 37°C.
Pepsin digestion time varied for different samples based
on amount of cytoplasm left after spinning cells on
slides or age of slides. The slides were washed three
times in 2X SSC and dehydrated in ethanol series. The
DNA on slides was denatured in 70% formamide and 2X
SSC at 80°C for 5 min. The slides were incubated in ice
cold 70% and 95% ethanol for 3 min each followed by
100% ethanol for 5 min at RT. Then denatured slides
were hybridized with pre-annealed for 20 to 24 h at 37°C.
At the end of hybridization, the slides were washed in
50% formamide and 2X SSC three times for 5 min each
at 45°C, 0.2X SSC four times for 5 min each at 65°C
and 2X SSC at room temperature once for 5 min. After
washing, slides were incubated with blocking buffer (4×
SSC/0.1% Tween-20, 3% bovine albumin) containing nor-
mal sheep or goat IgG (1:100 dilution) for 1 h at 37°C.
The slides were then incubated with 1:1000 dilution strep-
tavidin alexa 488 (Invitrogen, Grand Island, NY, USA) in
developing buffer (4X SSC/0.1% Tween 20, 1% BSA) con-
taining normal IgG for 1 h. The slides were washed in 4X
SSC/0.1% tween 20 solution four times at 45°C followed
by two washes in 2X SSC at room temperature. Slides
were air dried and mounted with aqueous mounting
media containing DAPI (Vector Labs, Burlingame, CA,
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system (Applied Precision, GE Healthcare, Issaquah,
WA, USA) controlling an interline charge-coupled device
camera (Coolsnap; Roper) mounted on inverted micro-
scope (IX-70; Olympus America, Center Valley, PA,
USA). Images were captured using the 100X objective
at 0.06 μm z-sections, de-convolved, and 2D-projected
using softWoRx (api.gehealthcare.com/api/softworx-suite.
asp). One hundred interphase cells were analyzed for
CENP-A and 8q24 for all cell lines. For tumors, the num-
ber of cells analyzed ranged from 70 to 85 except for one
tumor in which fifty cells were analyzed due to insufficient
material.
Tumor and matched normal tissue
Tumor/normal tissues were obtained from the CHTN
network. The pathology report indicated Tumor 1, Tumor
2, and Tumor 3 were moderately differentiated stage three
tumor with no metastasis, high grade poorly differentiated
stage three tumor with metastasis to one lymph node, and
low grade well differentiated stage three tumor with no
metastasis, respectively. Tumor cells were minced in buf-
fer containing 250 mM sucrose, 15 mM Tris- HCl PH 7.5,
15 mM NaCl, 60 mM KCl, 1 mM EDTA, 0.5 mM EGTA,
0.15 mM spermine, 0.5 mM Spermidine and protease
inhibitors (adapted from Dalal et al., 2005 [82]). Cells were
collected by centrifugation at 600 g (1500 rpm) for 10 min
at 4°C. The cell pellet was washed twice with same buffer.
The cell pellet was resuspended in buffer containing 2 M
sucrose instead of 250 mM and spun at 16,000× g for 30
min at 4°C. The cells were washed with buffer containing
no sucrose and cells were cytospun onto glass slides for
5 min at 600 rpm. The slides were air dried and processed
for IF and FISH as above.
Additional file
Additional file 1: Genome wide chromatin immunoprecipitation
(ChIP)-Seq and DNase I hypersensitivity (DHS)-Seq identifies CENP-A
and DHS sites in colorectal cancer cells. (A list of all hotspots
identified in this study (please find attached as an xls data/spreadsheet).
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